Clinical trial
Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
NCT03492099 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing the Safety of Buprenorphine in People With Sickle Cell Disease
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 1, 2018
- Completion date
- February 28, 2022
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease